(RTTNews) - bluebird bio, Inc. (BLUE) has commenced an underwritten public offering of 20 million shares of its common stock. The company intends to grant the underwriters a 30-day option to purchase ...
(RTTNews) - bluebird bio (BLUE) announced it is implementing a restructuring intended to optimize cost structure and enable quarterly cash flow break-even in the second half of 2025. The initiative ...
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and bluebird bio, Inc. (BLUE) announced a collaboration to apply their respective technology platforms to the discovery, development and ...
March 28 (Reuters) - Gene therapy maker bluebird bio (BLUE.O), opens new tab said on Friday it had received a non-binding offer from peer Ayrmid for up to $110.5 million, sending its shares up 9.8% at ...
(RTTNews) - bluebird bio, Inc. (BLUE) announced its intent to separate its severe genetic disease and oncology businesses into independent publicly traded companies. bluebird bio, Inc. will retain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback